Similar articles for PMID: 16087049

Year	Number of Results
1960	1
1961	1
1963	1
1968	1
1973	2
1975	1
1976	1
1978	2
1979	2
1981	2
1982	4
1983	7
1984	7
1985	11
1986	11
1987	12
1988	6
1989	14
1990	13
1991	12
1992	11
1993	15
1994	9
1995	9
1996	11
1997	5
1998	11
1999	7
2000	8
2001	14
2002	7
2003	7
2004	11
2005	28
2006	32
2007	24
2008	19
2009	13
2010	9
2011	17
2012	14
2013	8
2014	6
2015	10
2016	6
2017	10
2018	6
2019	8
2020	7
2021	5
2022	5
2023	3
2024	0

1

Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs.

Martino R, Gilard V, Desmoulin F, Malet-Martino M. Martino R, et al. J Pharm Biomed Anal. 2005 Aug 10;38(5):871-91. doi: 10.1016/j.jpba.2005.01.047. J Pharm Biomed Anal. 2005. PMID: 16087049 Review.

2

Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.

Malet-Martino M, Gilard V, Desmoulin F, Martino R. Malet-Martino M, et al. Clin Chim Acta. 2006 Apr;366(1-2):61-73. doi: 10.1016/j.cca.2005.10.013. Epub 2005 Dec 6. Clin Chim Acta. 2006. PMID: 16337167 Review.

3

Interest of fluorine-19 nuclear magnetic resonance spectroscopy in the detection, identification and quantification of metabolites of anticancer and antifungal fluoropyrimidine drugs in human biofluids.

Martino R, Gilard V, Desmoulin F, Malet-Martino M. Martino R, et al. Chemotherapy. 2006;52(5):215-9. doi: 10.1159/000094744. Epub 2006 Jul 25. Chemotherapy. 2006. PMID: 16864998 Review.

4

Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs.

Martino R, Malet-Martino M, Gilard V. Martino R, et al. Curr Drug Metab. 2000 Nov;1(3):271-303. doi: 10.2174/1389200003339036. Curr Drug Metab. 2000. PMID: 11465049 Review.

5

Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review.

Daly PF, Cohen JS. Daly PF, et al. Cancer Res. 1989 Feb 15;49(4):770-9. Cancer Res. 1989. PMID: 2643462 Review.

6

[Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines].

Malet-Martino MC, Martino R, Armand JP. Malet-Martino MC, et al. Bull Cancer. 1990;77(12):1223-44. Bull Cancer. 1990. PMID: 2081282 Review. French.

7

Alternate strategies to obtain mass balance without the use of radiolabeled compounds: application of quantitative fluorine (19F) nuclear magnetic resonance (NMR) spectroscopy in metabolism studies.

Mutlib A, Espina R, Atherton J, Wang J, Talaat R, Scatina J, Chandrasekaran A. Mutlib A, et al. Chem Res Toxicol. 2012 Mar 19;25(3):572-83. doi: 10.1021/tx2005629. Epub 2012 Feb 10. Chem Res Toxicol. 2012. PMID: 22292524

8

Magnetic resonance spectroscopy applied to clinical oncology.

Leach MO. Leach MO. Technol Health Care. 1994 Dec;2(4):235-46. Technol Health Care. 1994. PMID: 7842308 Review.

9

Solving problems fluorine 19F with NMR spectroscopy.

Gonet B. Gonet B. Med Sci Monit. 2001 May-Jun;7(3):489-95. Med Sci Monit. 2001. PMID: 11386031

10

19F NMR metabolomics for the elucidation of microbial degradation pathways of fluorophenols.

Boersma MG, Solyanikova IP, Van Berkel WJ, Vervoort J, Golovleva LA, Rietjens IM. Boersma MG, et al. J Ind Microbiol Biotechnol. 2001 Jan-Feb;26(1-2):22-34. J Ind Microbiol Biotechnol. 2001. PMID: 11548746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

433 results

Results by year